Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 153 pseudogene (RNU7-153P) is classified as a pseudogene of the U7 small nuclear RNA family[4]. The canonical U7 small nuclear RNA (snRNA) is an essential component of the U7 small nuclear ribonucleoprotein complex (U7 snRNP), primarily involved in the processing of histone pre-mRNA, specifically by facilitating the cleavage of the 3′ end of replication-dependent histone transcripts[1][5]. U7 snRNA recognizes a conserved downstream sequence (histone downstream element, HDE) to aid in precise histone mRNA maturation[1]. However, RNU7-153P is annotated as a pseudogene, meaning it is a DNA sequence similar to a functional gene but is considered non-functional due to mutations, truncations, or lack of necessary regulatory sequences[4][5]. There is no evidence that RNU7-153P produces a functional RNA product or participates in histone mRNA processing, nor is it regarded as a therapeutic target, disease gene, or biomarker[4][5]. Pseudogenes in the U7 family are common in primate genomes due to retrogene formation and gene duplication, but only the canonical U7 snRNA (for example, RNU7-1) is functional[5]. No disease association, interacting drugs, or safety considerations have been reported for RNU7-153P. The existence of RNU7-153P is primarily a consequence of gene duplication/evolutionary processes, and it should not be confused with the functional U7 snRNA required for histone RNA processing[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 153 pseudogene (RNU7-153P).